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a b s t r a c t
B-type natriuretic peptide (BNP) is a diagnostic and prognostic tool in heart failure and also in
Chagas disease, which is caused by the protozoan Trypanosoma cruzi and has cardiomyopathy as a
main feature. BNP lipolytic actions and T. cruzi infection in the adipose tissue have been recently
described. We aim to investigate the relationship between BNP and anthropometric measures and
whether it is inﬂuenced by T. cruzi infection. We measured BNP, body mass index (BMI), waist
circumference (WC), triceps skin-fold thickness (TSF) and performed serological, biochemical and
electrocardiographic exams in 1398 subjects (37.5% infected with T. cruzi) in a community-dwelling
elderly population in Bambui city, Brazil. Linear multivariate regression analysis was performed to
investigate determinants of BNP levels. BNP levels were signiﬁcantly (p<0.05) higher in T. cruzi-
infected subjects than in the non-infected group (median=121 and 64pg/mL, respectively). BMI,
WC and TSF in infected subjects were signiﬁcantly lower than those in non-infected subjects
(24.3 vs. 25.5 kg/m2; 89.2 vs. 92.4 cm; and 14.5 vs. 16.0mm, respectively). There was an inverse
relationship between BNP levels and BMI (b=−0.018), WC (b=−0.005) and TSF (b=−0.193) lev-
els. Infected and non-infected groups showed similar inverse relationships between BNP and BMI
(b=−0.021 and b=−0.015, respectively). In conclusion, there was an inverse relationship between BNP
levels and the anthropometricmeasures.Despite the actions in the adipose tissue, T. cruzi infectiondidnot
modify the associations between BNP and BMI, suggesting that body mass does not modify the accuracy
of BNP in Chagas disease.
. Introduction
B-type natriuretic peptide (BNP), a 32-amino-acid peptide
ember of the natriuretic peptide (NP) family, is released by
entricular cardiomyocytes under high pressure and volume over-
oad states. Vasodilation, diuresis, natriuresis, and inhibition of
he activities of the renin–angiotensin–aldosterone and the sym-
athetic nervous systems are among its hemodynamic actions. In
linical practice, BNPplasmaticmeasurement isusedbothas adiag-
ostic tool for exclusion of heart failure [22] and as a predictor of
Abbreviations: BNP, B-type natriuretic peptide; NP, natriuretic peptides; BMI,
odymass index;WC,waist circumference; TSF, triceps skin-fold thickness; T. cruzi,
rypanosomacruzi; ECG, electrocardiogram;EDTA, ethylenediaminetetraacetic acid;
EIA, microparticle-based immunoassay; NPAr, natriuretic peptide type-A recep-
or; cGMP, cyclic guanosine monophosphate; NPCr, natriuretic peptide clearance
eceptors; NT-proBNP, amino-terminal fraction of B-type natriuretic peptide.
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coronary heart disease, stroke, and other cardiovascular outcomes
[11]. An additional but lesswell-studied functionof BNP is its action
as a promoter of lipolysis in the adipose tissue,whichhas generated
speculation regarding its involvement in thebiologicalmechanisms
of obesity and cardiac cachexia [4,15,33]. Population-based stud-
ies performed in North America, Europe and Asia have shown that
body mass index (BMI) is inversely related to BNP levels, and, con-
sequently, obese individuals have lower BNP levels than lean ones,
even in the presence of heart failure [8,9,21,38]. Few studies have
addressed the inﬂuence of other measures of adiposity on BNP lev-
els that may be important in the application of the peptide as a
diagnostic or prognostic tool [9,34].
Cardiomyopathy is the main feature of Chagas disease [6], a
disorder caused by the protozoan Trypanosoma cruzi, endemic in
South America and Central America. It is characterized by heart
block, ventricular arrhythmia, and heart failure with left ventric-
Open access under the Elsevier OA license.ular systolic and/or diastolic dysfunction. Left ventricular systolic
and diastolic dysfunctions are associated with higher BNP levels
[2,30]. Recently, a large community-based study showed that there
was a graded and strong cross-sectional relationship between BNP
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evels and T. cruzi infection in old age and that BNP is an indepen-
entpredictor for the10-yearmortality rate in infectedelderly [17].
n addition, adipose tissue has been described as an important tar-
et organ for T. cruzi infection [25]. To our knowledge, the effect of
. cruzi infection on the relationship between BNP and BMI or other
nthropometric measures is unknown.
We aimed to investigate the relationship between BNP and
nthropometric measures (BMI, waist circumference and triceps
kin-fold thickness) in a large community-dwelling elderly popu-
ation in Brazil. An additional objective was to examine whether T.
ruzi infection has an inﬂuence on these associations.
. Materials and methods
.1. Study population
The study was conducted in Bambuí city (∼15,000 inhabitants),
hich is situated in the southeastern Brazil and is one of the oldest
nown endemic areas for Chagas disease. The procedures used in
he Bambuí Cohort Study of Aging have been described in detail
lsewhere [18]. Brieﬂy, the baseline cohort population comprised
ll residents who were 60 years old or older on January 1, 1997,
nd who were identiﬁed by means of a complete census conducted
n the city. A total of 1606 (92.2%) of the 1742 eligible residents
articipated. The present study is based on the baseline data col-
ection, performed in 1997, comprising standardized interviews,
lood tests, blood pressure measurements, and electrocardiogram
ECG).
Participants signed an informed consent form and authorized
eath-certiﬁcate veriﬁcation. The Bambuí Cohort Study of Aging
as approved by the ethics board of the Fundac¸ão Oswaldo Cruz,
io de Janeiro, Brazil.
.2. BNP measurement
Blood samples for the measurement of BNP were collected
n tubes containing ethylenediaminetetraacetic acid (EDTA).
NP was measured using a microparticle-based immunoassay
MEIA/AxSYM, Abbott Laboratories). The lower limits of detection
nd the average inter-assay coefﬁcients of variation were less than
5pg/mL and 12%, respectively. Subjects were asked to fast for
2h prior to an early-morning (6:30–8:30AM) phlebotomy. The
amples were aliquoted and stored at −80 ◦C until used.
.3. Body mass index and the other anthropometric measures
Anthropometric measures used in the analysis were BMI, waist
ircumference and triceps skin-fold thickness. Two high-precision
igital scales (range 0–150kg×0.1 kg) were used for the measure-
ent of weight (kg) and height (cm). BMI was calculated using
he conventional formula of weight in kilograms divided by the
quareof theheight inmeters. ACMSPortable Stadiometer kit (CMS
eighing Equipment Ltd., London) was used for measurements of
he waist circumference (WC) at umbilicus height and triceps skin-
old thickness (TSF) (mm). The reliability of these measurements
as determined by repeating them in a 5% cohort of all of the study
articipants [19]. All measures were performed with individuals
earing light clothing and no shoes.
.4. Trypanosoma cruzi infection
Infection with T. cruzi at baseline was assessed by concurrently
erforming a hemagglutination assay (Biolab Mérieux SA, Rio de
aneiro, Brazil) and two enzyme-linked immunosorbent assays
Abbott Laboratories, Inc., North Chicago, IL; and Wiener Labora-
ories, Rosario, Argentina). The agreement (Cohen’s kappa) among32 (2011) 1787–1792
these assays was 0.989 (p<0.001). Seropositivity in all three exam-
inations was the criterion for the presence of infection; absence of
infection was deﬁned as consistent seronegativity.
2.5. Other measures
The following other measures that had been previously
described as being associated with BNP levels were included in
this study: age, sex, systolic blood pressure, diabetes mellitus,
creatinine, and possible old myocardial infarction [24,37,39]. In
addition, the ECG abnormalities related with Chagas disease that
have already been associated with increased BNP levels in Bambui
cohort population were considered in the analysis [17]. Systolic
blood pressure was deﬁned as the mean of two out of three mea-
surements using standard protocols. Fasting blood glucose and
creatinine levels were assessed by traditional enzymatic methods.
Diabetes was deﬁned as a 12-h-fast glucose ≥126mg/dL and/or the
use of insulin or oral hypoglycemic agents. Electrocardiographic
variables were veriﬁed by 12-lead ECGs digitally recorded at rest
using standardized procedures. ECGs were analyzed by experi-
enced cardiologists at the ECG Reading Center (EPICARE Center,
Wake Forest University School of Medicine, Winston-Salem, NC)
and classiﬁed according to the Minnesota code criteria [29]. ECG
abnormalities considered in this study were possible history of
myocardial infarction (Minnesota codes 1.3.x and 4.1.x, 4.2, 5.1, or
5.2), complete intra-ventricular block (Minnesota code 7.1, 7.2, 7.4,
or 7.8) and frequent ventricular premature beats (Minnesota code
8.1.2 or 8.1.3).
2.6. Statistical analysis
Veriﬁcation of the normal distribution of continuous data was
accomplishedbyconstructionofhistogramsandnormalplots.Vari-
ableswithaskeweddistributionwere log-transformed.Continuous
variables were described by the mean and standard deviation or
the median and the inter-quartile range. Participant characteris-
tics, stratiﬁed by T. cruzi-infection, were compared by the Student’s
t-test, Pearson’s chi-square test or the Mann–Whitney two-sample
rank-sum test for differences betweenmeans, frequencies ormedi-
ans, respectively. Multivariable linear regression models were
performed to assess the associationof logBNPwith anthropometric
measures (BMI, waist circumference and triceps skin-fold thick-
ness) adjusting to age, sex, Chagas disease, systolic blood pressure,
diabetes mellitus, log-transformed serum creatinine levels, pos-
sible history of myocardial infarction, complete intra-ventricular
block and frequent ventricular premature beats on an ECG for the
whole population and for T. cruzi infected and non-infected groups
separately. Afterwards, we compared the regression coefﬁcients of
infected persons with non-infected persons (Ho: BCHD =Bnon-CHD,
where BCHD is the regression coefﬁcient for infected and Bnon-CHD
is the regression coefﬁcient for non-infected) [1]. All tests were
two-sided and a signiﬁcance level of 5% was used. Statistical anal-
yses were conducted using STATA 10.1 statistical software (Stata
Corporation, College Station, TX).
3. Results
Of the 1606 cohort subjects enrolled, 1398 participants (87.1%)
for whom complete data on all study variables were available were
included in this analysis. Exclusion criteria included the absence of
blood tests for BNP concentration and/or T. cruzi infection (n=132),
missing data for any other variable in the study (n=59), and incon-
clusive results for T. cruzi infection (n=17). The subjects included
in the analysis were younger than those who were excluded (mean
ages were 68.9 years (standard deviation (SD), 7.0) and 72.4 years
(SD, 9.3), respectively; p<0.001).
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Table 1
Characteristics of total and Trypanosoma cruzi-infected and non-infected participants.
Characteristics Total (n 1398) Trypanosoma cruzi infection p-Value
Yes (n=524) No (n=874)
Age, mean (SD) 68.9 (7.0) 69.2 (6.9) 68.6 (7.0) 0.108
Female sex, n (%) 850 (60.8) 396 (67.9) 454 (56.5) <0.001
BNP in pg/ml, median (IQR) 80 (43–148) 121 (63–204.5) 64 (34–112) <0.001
Body mass index in kg/m2, mean (SD) 25.0 (4.9) 24.3 (5.0) 25.5 (4.8) <0.001
Waist circumference in cm, mean (SD) 91.2 (11.2) 89.2 (11.2) 92.4 (11.0) <0.001
Skin-fold thickness in mm, median (IQR) 15.5 (10.2–22.4) 14.5 (10.2–22.2) 16.0 (11.0–23.0) 0.042
Systolic blood pressure in mm Hg, mean (SD) 137.4 (22.4) 135.5 (22.90) 138.6 (22.0) 0.012
Diabetes mellitus, n (%) 200 (14.3) 55 (10.5) 145 (16.6) 0.002
Serum creatinine in mg/dL, median (IQR) 0.85 (0.75–0.99) 0.85 (0.76–0.98) 0.85 (0.75–0.99) 0.601
Potential prior myocardial infarction, n (%) 57 (4.1) 29 (5.5) 28 (3.2) 0.036
Intraventricular block, n (%) 191 (13.7) 144 (27.5) 47 (5.4) <0.001
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eFrequent premature beats, n (%) 90 (6.4)
Pathological Q wave, n (%) 57 (4.1)
-Value: Student’s t-test, Pearson’s chi-square test and the Mann–Whitney two-sam
The baseline prevalence of T. cruzi infection was 37.5%, com-
rising 524 and 874 participants in the T. cruzi-infected and
on-infected groups, respectively. Females were predominant in
oth groups (67.9% and 56.5%, respectively). The median BNP level
as 80pg/mL (interquartile range (IQ) 43–148), with signiﬁcantly
igher values in the T. cruzi-infected than in the non-infected
roup (median BNP 121pg/mL (IQ, 63–204.5) versus 64pg/mL (IQ
4–112), respectively). Regarding the anthropometric measures,
MI was signiﬁcantly lower in the T. cruzi-infected than in the non-
nfected group (24.3 (SD 5.0) versus 25.5 (SD 4.8), respectively).
aist circumference (89.2 cm (SD 11.2) versus 92.4 cm (SD 11.0))
nd triceps skin-fold thickness (14.5mm (IQ 10.2–22.2) versus
6.0mm (IQ 11.0–23.0)) were signiﬁcantly lower in infected than
n non-infected individuals. Overall participant characteristics and
haracteristics for each group are depicted in Table 1.
We found an inverse relationship between BNP levels and BMI,
hich was independent of age and sex (B=−0.024; 95% CI −0.034
o −0.013; p<0.001). This association remained highly signiﬁ-
ant in the fully adjusted model (B=−0.018; 95% CI −0.028 to
0.008; p<0.001). We also found an inverse association between
aist circumference and BNP levels in the age–sex adjusted model
B=−0.008; 95% CI −0.013 to −0.004; p<0.001) and in the fully
djustedmodel (B=−0.005; 95%CI−0.010 to−0.001; p<0.05). Fur-
hermore, an inverse relationship between BNP levels and triceps
kin-fold thickness was also found in both univariate and adjusted
odels (B=−0.193; 95% CI −0.306 to −0.081; p<0.01)
Both T. cruzi-infected (B=−0.021; 95% CI −0.039 to −0.005;
=0.013) and non-infected (B=−0.015; 95% CI −0.028 to −0.003;
=0.017) subjects showed a signiﬁcant inverse association
etween BNP levels and BMI. Statistically signiﬁcant associations
etween BNP levels and waist circumference (B=−0.009; 95%
I −0.017 to −0.002; p=0.017) and triceps skin-fold thickness
B=−0.328; 95% CI −0.517 to −0.139; p=0.001) were veriﬁed
mong T. cruzi-infected subjects; however, this association was
ot statistically signiﬁcant in the non-infected group (B=−0.003;
I −0.008 to 0.002; p=0.222 and B=−0.105; CI −0.246 to 0.362;
=0.145, respectively). In addition, thedifferencesof the regression
oefﬁcientsbetween the infectedandnon-infectedgroupswerenot
tatistically signiﬁcant for anyof theanthropometricmeasures con-
idered in thepresent analysis (p-values =0.562, 0.178and0.390 for
MI, waist circumference and log triceps skin-fold, respectively).
ee Fig. 1 for crude correlations between log BNP and the anthro-
ometric measures among infected and non-infected individuals.. Discussion
The results of this cross-sectional study of community-dwelling
lderly with a high prevalence of T. cruzi infection showed an53 (10.1) 37 (4.2) <0.001
29 (5.5) 28 (3.2) 0.024
nk-sum test for differences between means, frequencies and medians, respectively.
inverse relationship between BMI and BNP levels. This associa-
tion was independent of age, sex, systolic blood pressure, diabetes
mellitus, blood creatinine, and selected ECG abnormalities previ-
ously reported as being associated with increased BNP levels. Most
important, our results showed for the ﬁrst time that this inverse
association is also present in elderly individuals infected with
T. cruzi.
Population-based studies have demonstrated an inverse rela-
tionship between BNP and BMI [9,34,38]. This relationship seems
to be consistent throughout diverse clinical contexts, such as
acute dyspnea in the emergency department [21] and ambulatory
patientswithmetabolic syndrome [37]. A recent review performed
by our group showed low BNP levels in obese subjects, even when
they presented with heart failure [4]. Lower BNP levels have been
proposed to maintain the diagnostic accuracy of the peptide in
obese patients [8]. To the best of our knowledge, none of these
studies speciﬁcally addressed the relationship between BNP and
BMI in elderly subjects.
The ﬁndings of an inverse association between BNP and BMI
are considered paradoxical because higher BMI levels are asso-
ciated with a pressure and volume overload in the heart, which
should lead to increased BNP secretion by cardiomyocytes. Most
likely, there is a connection between the recently described action
of NP as potent activators of lipolysis in adipocytes, their role in the
perpetuation of obesity states and the paradoxically low levels of
BNP in obese subjects [32]. Binding of NP to the trans-membrane
type-A receptor (NPAr) in adipocytes leads to increased levels of
cyclic guanosine monophosphate (cGMP) and the activation of
human phospholipase and perilipin A. This activation ultimately
results in the hydrolyzation of triglycerides into non-esteriﬁed
fatty acids and glycerol [33]. NP clearance receptors (NPCr) are
also highly expressed in human adipose tissue and could con-
tribute to increased clearance and the consequent low levels of
circulating NP in obesity. However, the fact that the biologically
inactive amino-terminal fraction of BNP (NT-proBNP), which is not
degraded by NPCr, is also decreased in obese persons weakens this
hypothesis [31]. Hence, alternative explanations for the reduced
levels of BNP in obese subjects involve increased degradation of
NP by neutral endopeptidases, which are zinc metallo-peptidases
widely expressed in the vasculature, or by the action of phospho-
diesterases, which are biological regulators of cGMP activity [23].
BNP has an important role in diagnosis and prognosis of various
cardiac abnormalities, such asheart failure [5] and coronarydisease
[14,20]. In the elderly, BNP is an independent predictor of mor-
tality from heart failure [12,28] and from non-cardiac conditions
[3,36,40]. BMI is also a predictor of overall mortality in the elderly:
underweight and obese older subjects are at greater risk of death
than normal weight and overweight persons [7]. BMI also predicts
1790 A.M. Beleigoli et al. / Peptides 32 (2011) 1787–1792
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Big. 1. Correlation between log-transformed B-type natriuretic peptide (BNP) lev
mong individuals infected and non-infected with Trypanossoma cruzi.
ortality in subjects with heart failure, with lower mortality rates
n the overweight and obese categories, a phenomenon called
besity paradox [27]. Thus, it is appropriate to consider whether
he relation between BNP and BMI affects the prognostic role of
NP. In subjects with Chagas disease, increased BNP levels ared body mass index, waist circumference and log-transformed skin-fold thickness
independent predictors of mortality in both clinical settings and
in the community [17]; however, the inﬂuence of BMI on this
association warrants further investigation.
Adipocytes are an important target of T. cruzi infection and a
reservoir fromwhich parasites can be reactivated during periods of
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mmunosuppression [25,26]. Furthermore, individualswithChagas
iseaseandchronicheart failurewithhighNP levelshave low leptin
evels that are independent of BMI levels [13]. We sought to deter-
ine whether there is a connection between natriuretic peptides,
he inﬂammatoryphenotype inducedby infection in the adipocytes
nd the consequences on adipocytokines. The denervation of the
ympathetic nervous system induced by T. cruzi in both the heart
nd the adipose tissue [10] can also be related to energy stores,
etabolic proﬁle and BMI in Chagas disease. We found an inverse
elationship between BNP and waist circumference and skin-fold
hickness, which are measures of visceral and subcutaneous fat
ass, respectively [16]. Few population-based studies have inves-
igated the relationship between BNP levels and these markers of
at mass [9,34,35]. Our results are consistent with the ﬁndings of
n Asian cohort, which detected that these two components of fat
ass were inversely related to BNP levels [34]. Conversely, the
esults of another large-based population cohort with individu-
ls aged 30–65 years found only lean mass to be inversely related
o BNP [9]. Apparently only infected subjects showed a signiﬁcant
nverse association between BNP and visceral and subcutaneous fat
ass after stratiﬁcation to Chagas disease. Further analysis demon-
trated that there was no difference in the B coefﬁcient between
he infected and non-infected groups. These controversial results
ndicate the need for larger studies regarding the issue.
The major strengths of this study include the composition and
ize of the population based sample, the standardized measure-
ent of parameters, and the inclusion of cardiovascular disease
isk factors and several other factors previously described as being
ssociated with BNP levels. The high prevalence of T. cruzi infection
akes the Bambuí Cohort unique for studying the inﬂuence of BMI
nd body composition for the potential prognostic clinical use of
NP inChagasdisease.However, this studywas limitedby its inabil-
ty to make conclusions on the temporal relationship between BNP
evels and anthropometric measures, owing to its cross-sectional
ature.
. Conclusions
In conclusion, our results showed an inverse relationship
etweenBNP levels andBMI,waist circumference, and triceps skin-
old thickness. This ﬁnding is probably related to BNP metabolic
ctions thathavealreadybeendemonstratedbyexperimental stud-
es. We also found that T. cruzi infection does not modify the nature
f these associations.
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Glossary
Trypanosoma cruzi:protozoanwhich is endemic in SouthAmerica andCentral Amer-
ica.
Chagas disease: disease caused by the infection by Trypanosoma cruzi. The main
clinical characteristics are the cardiomyopathy and the gastrointestinal disor-
ders. In some cases, there is serological infection, but not clinical manifestations
(indeterminate form).
Chagas disease: disease caused by the infection by Trypanosoma cruzi. The main
clinical characteristics are the cardiomyopathy and the gastrointestinal disor-
ders. In some cases, there is serological infection, but not clinical manifestations
(indeterminate form).
Acute coronary syndrome: lack of adequate blood supply for the myocardium due to
partial or complete obstruction of the coronary arteries. It results in two main
clinical manifestations: angina and myocardial infarction.
Complete intra-ventricular block: disorder of the electrical conduction in the heart.
Frequent ventricular premature beats: disorder of the electrical conduction in the
heart characterized by the occurrence of a premature beat. It is considered
frequent when it occurs at least six times in a minute.Dyspnea: feeling or sensation of heavy and difﬁcult breath.
Heart failure: clinical syndrome resultant of the inappropriate blood ejection and/or
ﬁlling of the heart.
